Nobutaka Koibuchi

Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice

Bo-Wen Lin, Nobutaka Koibuchi, Yu Hasegawa et al. · Cardiovascular Diabetology · 2014 · 422 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Estrogen Inhibits Vascular Calcification via Vascular RANKL System

Mariana Kiomy Osako, Hironori Nakagami, Nobutaka Koibuchi et al. · Circulation Research · 2010 · 215 citations · Full text

Medicine, Endocrinology, Molecular Biology +17

Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome

Hiroaki Kusaka, Nobutaka Koibuchi, Yu Hasegawa et al. · Cardiovascular Diabetology · 2016 · 152 citations · Full text

Medicine, Endocrinology, Pharmacology +16

Perindopril, a centrally active angiotensin‐converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease

Yi‐Fei Dong, Keiichiro Kataoka, Yoshiko Tokutomi et al. · The FASEB Journal · 2011 · 140 citations

Medicine, Neuroscience, Pharmacology +17

CHF1/Hey2 Plays a Pivotal Role in Left Ventricular Maturation Through Suppression of Ectopic Atrial Gene Expression

Nobutaka Koibuchi, Michael T. Chin · Circulation Research · 2007 · 128 citations

Life Sciences, Cardiology, Genetics +7